Logo

Invitrogen and Novartis Institute in Research Deal

Dec 31, 1999
Premium

S

AN DIEGO, Calif.--Invitrogen and the Novartis Institute for Functional Genomics announced that they will collaborate to develop collections of full-length genes for expression and protein structural studies. The Novartis institute will gain access to Invitrogen’s advanced cloning technologies and expression systems in order to develop new reagents for research. Invitrogen said that tools developed through the collaboration will strengthen its Invirtro-genomics program that provides tools and services to genomic researchers.

Filed under

Informatics
Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.